Denali Advisors LLC Has $4.39 Million Holdings in Hercules Capital, Inc. $HTGC

Denali Advisors LLC cut its holdings in shares of Hercules Capital, Inc. (NYSE:HTGC) by 12.2% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 233,249 shares of the financial services provider’s stock after selling 32,327 shares during the quarter. Denali Advisors LLC owned 0.13% of Hercules Capital worth $4,390,000 at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of HTGC. Marshall Wace LLP acquired a new stake in Hercules Capital during the 3rd quarter worth about $11,199,000. Qube Research & Technologies Ltd lifted its holdings in shares of Hercules Capital by 425.6% during the 2nd quarter. Qube Research & Technologies Ltd now owns 580,414 shares of the financial services provider’s stock valued at $10,610,000 after buying an additional 469,989 shares during the last quarter. UBS Group AG lifted its holdings in shares of Hercules Capital by 26.8% during the 4th quarter. UBS Group AG now owns 1,671,860 shares of the financial services provider’s stock valued at $31,464,000 after buying an additional 353,092 shares during the last quarter. Muzinich & Co. Inc. lifted its holdings in shares of Hercules Capital by 34.5% during the 4th quarter. Muzinich & Co. Inc. now owns 1,335,787 shares of the financial services provider’s stock valued at $25,140,000 after buying an additional 342,967 shares during the last quarter. Finally, HRT Financial LP lifted its holdings in shares of Hercules Capital by 100.9% during the 2nd quarter. HRT Financial LP now owns 558,010 shares of the financial services provider’s stock valued at $10,200,000 after buying an additional 280,198 shares during the last quarter. 19.69% of the stock is currently owned by institutional investors and hedge funds.

Key Stories Impacting Hercules Capital

Here are the key news stories impacting Hercules Capital this week:

• Negative Sentiment: Multiple law firms on May 7-8 reminded investors about a May 19 lead-plaintiff deadline in an already-filed securities class action against Hercules Capital, increasing the market’s focus on alleged investor harm and possible litigation costs. Article Title
• Negative Sentiment: Additional notices from firms including Faruqi & Faruqi, The Gross Law Firm, Rosen Law Firm, Pomerantz, Bronstein Gewirtz & Grossman, and others kept the class-action story in front of investors, reinforcing uncertainty around the company’s disclosures during the May 1, 2025 to Feb. 27, 2026 class period. Article Title
• Neutral Sentiment: A Seeking Alpha piece argued Hercules Capital still has solid portfolio quality and dividend coverage, suggesting the selloff may be more about valuation and legal headlines than a collapse in fundamentals. Article Title
• Neutral Sentiment: The company also announced the date of its 2026 annual stockholders meeting, which is routine corporate news and unlikely to move the stock on its own. Article Title

Insider Transactions at Hercules Capital

In related news, Director Robert P. Badavas bought 5,000 shares of Hercules Capital stock in a transaction that occurred on Friday, February 27th. The stock was purchased at an average cost of $14.27 per share, for a total transaction of $71,350.00. Following the acquisition, the director owned 122,073 shares in the company, valued at $1,741,981.71. This trade represents a 4.27% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CFO Seth H. Meyer bought 7,000 shares of Hercules Capital stock in a transaction that occurred on Friday, February 27th. The stock was bought at an average price of $14.33 per share, with a total value of $100,310.00. Following the completion of the acquisition, the chief financial officer owned 448,553 shares in the company, valued at approximately $6,427,764.49. The trade was a 1.59% increase in their position. The disclosure for this purchase is available in the SEC filing. In the last quarter, insiders acquired 117,015 shares of company stock worth $1,749,620. 1.80% of the stock is currently owned by company insiders.

Hercules Capital Stock Down 1.4%

HTGC opened at $16.18 on Friday. The business has a 50 day moving average price of $14.99 and a 200 day moving average price of $16.90. Hercules Capital, Inc. has a twelve month low of $13.70 and a twelve month high of $19.67. The company has a debt-to-equity ratio of 1.14, a quick ratio of 1.48 and a current ratio of 1.89. The firm has a market cap of $3.03 billion, a P/E ratio of 9.14 and a beta of 0.82.

Hercules Capital (NYSE:HTGC) last posted its earnings results on Tuesday, May 5th. The financial services provider reported $0.48 earnings per share for the quarter, topping the consensus estimate of $0.47 by $0.01. Hercules Capital had a return on equity of 16.05% and a net margin of 59.85%.The firm had revenue of $134.94 million during the quarter, compared to analyst estimates of $141.39 million. During the same period in the previous year, the company earned $0.45 EPS. The company’s revenue for the quarter was up 18.4% on a year-over-year basis. Research analysts forecast that Hercules Capital, Inc. will post 1.93 EPS for the current year.

Hercules Capital Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, May 21st. Investors of record on Thursday, May 14th will be issued a $0.07 dividend. This represents a $0.28 annualized dividend and a yield of 1.7%. The ex-dividend date is Thursday, May 14th. Hercules Capital’s payout ratio is 90.40%.

Analysts Set New Price Targets

Several equities research analysts have recently issued reports on HTGC shares. Piper Sandler lifted their price target on Hercules Capital from $16.50 to $17.00 and gave the company a “neutral” rating in a report on Wednesday. Keefe, Bruyette & Woods reduced their price target on Hercules Capital from $19.00 to $18.00 and set an “outperform” rating for the company in a report on Thursday, April 16th. Weiss Ratings lowered Hercules Capital from a “buy (b-)” rating to a “hold (c+)” rating in a report on Tuesday, February 24th. UBS Group reduced their price target on Hercules Capital from $19.50 to $15.00 and set a “neutral” rating for the company in a report on Friday, March 13th. Finally, Wells Fargo & Company reduced their price target on Hercules Capital from $18.00 to $17.00 and set an “overweight” rating for the company in a report on Friday, February 13th. One equities research analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat, Hercules Capital currently has a consensus rating of “Moderate Buy” and a consensus target price of $18.13.

Hercules Capital Profile

Hercules Capital, Inc is a specialty finance company organized as a business development company (BDC) that provides tailored debt financing solutions to high‐growth companies. Through its external management structure, Hercules Capital extends senior secured loans, subordinated debt and growth capital designed to support research and development, expansion initiatives and working capital needs. The firm primarily partners with venture capital and private equity sponsors to finance innovative enterprises across various developmental stages.

The company’s investment portfolio is concentrated in technology, life sciences and sustainable and renewable technology sectors, reflecting its focus on industries with strong growth prospects and recurring capital requirements.